# The Sustained Effects of Ketamine

> **NCT02708849** · PHASE1 · TERMINATED · sponsor: **Yale University** · enrollment: 3 (actual)

## Conditions studied

- Mental Disorders

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Lamotrigine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02708849
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-06
- **Primary completion:** 2020-03
- **Final completion:** 2020-03
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02708849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02708849, "The Sustained Effects of Ketamine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02708849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
